SILVAPHL Stock Overview
Engages in manufacture and marketing of pharmaceutical products in Bangladesh and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Silva Pharmaceuticals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ৳10.40 |
| 52 Week High | ৳21.60 |
| 52 Week Low | ৳8.60 |
| Beta | 0.053 |
| 1 Month Change | 6.12% |
| 3 Month Change | -25.71% |
| 1 Year Change | -51.85% |
| 3 Year Change | -42.22% |
| 5 Year Change | -38.10% |
| Change since IPO | -62.34% |
Recent News & Updates
Recent updates
Shareholder Returns
| SILVAPHL | BD Pharmaceuticals | BD Market | |
|---|---|---|---|
| 7D | 2.0% | 5.0% | 2.1% |
| 1Y | -51.9% | -24.3% | -21.0% |
Return vs Industry: SILVAPHL underperformed the BD Pharmaceuticals industry which returned -24.3% over the past year.
Return vs Market: SILVAPHL underperformed the BD Market which returned -21% over the past year.
Price Volatility
| SILVAPHL volatility | |
|---|---|
| SILVAPHL Average Weekly Movement | 8.5% |
| Pharmaceuticals Industry Average Movement | 7.6% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in BD Market | 9.0% |
| 10% least volatile stocks in BD Market | 3.5% |
Stable Share Price: SILVAPHL's share price has been volatile over the past 3 months compared to the BD market.
Volatility Over Time: SILVAPHL's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of BD stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 571 | Saira Khan | www.silvapharma.com |
Silva Pharmaceuticals Limited engages in manufacture and marketing of pharmaceutical products in Bangladesh and internationally. The company offers drugs for various categories, including antibiotics, analgesics, anti-diabetics, narcotics, anti-pyretics, anti-inflammatory, anti ulcerants, antiemetic, gastroprokinetic, anti histamine, anti spasmodic expectorants, and vitamins and mineral. It also provides pharmaceutical products in various therapeutic area, such as anemias and other blood disorders, central nervous system, anti infectives, respiratory system, cardiovascular system, endocrine system, and natural sweetener; agrovet and pesticides products; and herbal and nutraceuticals products comprising anti-tussive and expectorant, hepato-protective, CNS and antidepressant, adaptogen and Immuno modulator, hematinic, gastrointestinal, and hormonal products.
Silva Pharmaceuticals Limited Fundamentals Summary
| SILVAPHL fundamental statistics | |
|---|---|
| Market cap | ৳1.42b |
| Earnings (TTM) | -৳89.76m |
| Revenue (TTM) | ৳547.07m |
2.6x
P/S Ratio-15.8x
P/E RatioIs SILVAPHL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SILVAPHL income statement (TTM) | |
|---|---|
| Revenue | ৳547.07m |
| Cost of Revenue | ৳404.27m |
| Gross Profit | ৳142.80m |
| Other Expenses | ৳232.56m |
| Earnings | -৳89.76m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.66 |
| Gross Margin | 26.10% |
| Net Profit Margin | -16.41% |
| Debt/Equity Ratio | 2.2% |
How did SILVAPHL perform over the long term?
See historical performance and comparisonDividends
1.0%
Current Dividend Yield-15%
Payout RatioDoes SILVAPHL pay a reliable dividends?
See SILVAPHL dividend history and benchmarks| Silva Pharmaceuticals dividend dates | |
|---|---|
| Ex Dividend Date | Dec 02 2024 |
| Dividend Pay Date | Jan 29 2025 |
| Days until Ex dividend | 20 days |
| Days until Dividend pay date | 38 days |
Does SILVAPHL pay a reliable dividends?
See SILVAPHL dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 02:13 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Silva Pharmaceuticals Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|